Pfizer Limited (NSE:PFIZER) — Stock Price
Pfizer Limited (NSE:PFIZER) is currently trading at Rs4877.60 INR, down 0.06% today. Over the past 52 weeks, shares have ranged between Rs4404.90 and Rs5766.50. This page tracks Pfizer Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Pfizer Limited.
Pfizer Limited (PFIZER) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Pfizer Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Pfizer Limited Income Statement — Revenue, Profit & Earnings by Year
Pfizer Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | Rs25.20 Billion | Rs22.81 Billion | Rs21.93 Billion | Rs24.25 Billion | Rs26.11 Billion |
| Cost of Revenue | Rs13.10 Billion | Rs8.16 Billion | Rs7.98 Billion | Rs8.78 Billion | Rs9.53 Billion |
| Gross Profit | Rs12.10 Billion | Rs14.66 Billion | Rs13.95 Billion | Rs15.47 Billion | Rs16.58 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | — | Rs3.72 Billion | Rs3.48 Billion | Rs3.32 Billion | Rs4.04 Billion |
| Total Operating Expenses | Rs3.63 Billion | Rs4.29 Billion | Rs4.34 Billion | Rs3.93 Billion | Rs4.78 Billion |
| Operating Income | Rs8.46 Billion | Rs10.37 Billion | Rs9.61 Billion | Rs11.53 Billion | Rs11.80 Billion |
| EBITDA | Rs9.04 Billion | Rs7.05 Billion | Rs5.99 Billion | Rs7.70 Billion | Rs7.88 Billion |
| EBIT | Rs8.46 Billion | Rs6.81 Billion | Rs5.77 Billion | Rs7.05 Billion | Rs7.22 Billion |
| Interest Expense | Rs94.80 Million | Rs85.00 Million | Rs154.30 Million | Rs133.90 Million | Rs107.00 Million |
| Income Before Tax | Rs9.76 Billion | Rs10.16 Billion | Rs7.46 Billion | Rs8.24 Billion | Rs7.73 Billion |
| Income Tax Expense | Rs2.53 Billion | Rs2.48 Billion | Rs1.95 Billion | Rs2.00 Billion | Rs1.60 Billion |
| Net Income | Rs7.22 Billion | Rs7.68 Billion | Rs5.51 Billion | Rs6.24 Billion | Rs6.13 Billion |
Pfizer Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Pfizer Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | Rs49.22 Billion | Rs49.11 Billion | Rs42.29 Billion | Rs40.01 Billion | Rs39.01 Billion |
| Total Current Assets | Rs38.03 Billion | Rs35.13 Billion | Rs27.70 Billion | Rs25.25 Billion | Rs23.96 Billion |
| Cash & Equivalents | — | Rs4.93 Billion | Rs1.08 Billion | Rs287.00 Million | Rs340.00 Million |
| Short-term Investments | Rs30.11 Billion | Rs22.88 Billion | Rs19.15 Billion | Rs18.03 Billion | Rs15.47 Billion |
| Net Receivables | Rs1.82 Billion | Rs1.93 Billion | Rs1.88 Billion | Rs2.39 Billion | Rs1.92 Billion |
| Inventory | Rs4.73 Billion | Rs4.76 Billion | Rs4.34 Billion | Rs4.34 Billion | Rs4.18 Billion |
| Property, Plant & Equipment | — | Rs1.79 Billion | Rs1.51 Billion | Rs1.85 Billion | Rs2.20 Billion |
| Goodwill | Rs5.27 Billion | Rs5.27 Billion | Rs5.27 Billion | Rs5.27 Billion | Rs5.27 Billion |
| Total Liabilities | Rs7.19 Billion | Rs6.94 Billion | Rs6.33 Billion | Rs7.93 Billion | Rs10.36 Billion |
| Total Current Liabilities | Rs6.27 Billion | Rs5.70 Billion | Rs5.47 Billion | Rs6.57 Billion | Rs8.53 Billion |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Rs-30.41 Billion | Rs-26.93 Billion | Rs-174.60 Million | Rs978.70 Million | Rs1.04 Billion |
| Total Stockholder Equity | Rs42.03 Billion | Rs42.17 Billion | Rs35.96 Billion | Rs32.07 Billion | Rs28.64 Billion |
| Retained Earnings | — | Rs24.36 Billion | Rs18.28 Billion | Rs14.60 Billion | Rs11.33 Billion |
Pfizer Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Pfizer Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs11.44 Billion | Rs6.60 Billion | Rs2.57 Billion | Rs3.56 Billion | Rs6.67 Billion |
| Capital Expenditures | Rs252.30 Million | Rs281.50 Million | Rs189.30 Million | Rs649.80 Million | Rs153.10 Million |
| Free Cash Flow | Rs11.18 Billion | Rs6.32 Billion | Rs2.38 Billion | Rs2.91 Billion | Rs6.52 Billion |
| Investing Cash Flow | Rs-7.39 Billion | Rs-713.40 Million | Rs-713.40 Million | Rs-360.50 Million | Rs-5.75 Billion |
| Financing Cash Flow | Rs-7.97 Billion | Rs-2.05 Billion | Rs-2.05 Billion | Rs-3.46 Billion | Rs-1.81 Billion |
| Dividends Paid | Rs7.52 Billion | Rs1.60 Billion | Rs1.83 Billion | Rs2.97 Billion | Rs1.60 Billion |
| Stock-Based Compensation | Rs140.60 Million | Rs136.60 Million | Rs144.50 Million | Rs127.00 Million | Rs117.70 Million |
| Depreciation | Rs577.30 Million | Rs607.90 Million | Rs622.80 Million | Rs1.06 Billion | Rs1.15 Billion |
| Change in Cash | Rs25.97 Billion | Rs3.83 Billion | Rs754.00 Million | Rs-261.60 Million | Rs-884.50 Million |
Pfizer Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Pfizer Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 12, 2026 | — | — | — |
| May 12, 2026 | — | 35.50 | — |
| Feb 09, 2026 | 40.42 | 35.70 | +13.22% |
| Nov 12, 2025 | 41.32 | 42.30 | -2.32% |
| Jul 28, 2025 | — | — | — |
| May 19, 2025 | 41.00 | 36.30 | +12.95% |
| Jan 31, 2025 | 27.89 | 31.80 | -12.30% |
| Oct 28, 2024 | 34.61 | 37.00 | -6.46% |